| |
|
|
|
|
|
|
|||
|
Blood, 8 January 2009, Vol. 113, No. 2, pp. 358-369. Prepublished online as a Blood First Edition Paper on October 15, 2008; DOI 10.1182/blood-2008-03-145615.
Submitted March 24, 2008
Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany * Corresponding author; email: alexander.steinle{at}uni-tuebingen.de.
NKp80, an activating homodimeric C-type lectin-like receptor (CTLR), is expressed on essentially all human NK cells and stimulates their cytotoxicity and cytokine release. Recently, we demonstrated that the ligand for NKp80 is the myeloid-specific CTLR AICL which is encoded in the Natural Killer Gene complex (NKC) adjacent to NKp80. Here we show that NKp80 is also expressed on a minor fraction of human CD8 T cells which exhibit a high responsiveness and an effector memory phenotype. Gene expression profiling and flow cytometric analyses revealed that this NKp80+ T cells subset is characterized by the co-expression of other NK receptors and increased levels of cytotoxic effector molecules and adhesion molecules mediating access to sites of inflammation. NKp80 ligation augmented CD3-stimulated degranulation and IFN
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2008 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||